Susunod

Auto-play

Saar Gill, MD: Combining CAR T-Cell Therapy With Ibrutinib in CLL Patients

1 Mga view • 07/14/23
Ibahagi
I-embed
administrator
administrator
Mga subscriber
0

Adding ibrutinib to treatment with CAR T-cell therapy was feasible, led to deeper remissions, and reduced the severity of cytokine release syndrome in patients with chronic lymphocytic leukemia.

Magpakita ng higit pa
0 Mga komento sort Pagbukud-bukurin Ayon
Mga Komento sa Facebook

Susunod

Auto-play